OxyContin Tablets

The FDA examiner who approved OxyContin's initial application allowed the company to include this note on the package. Delayed absorption as provided by OxyContin tablets is believed to reduce the abuse liability of a drug. In 1996, the year after OxyContin's release, Curtis Wright quit the FDA. He was hired by another pharmaceutical company for a short while and then hired by Purdue Pharmaceuticals. As Square talked to him years later, he offered this defense: "We didn't know people would do the thing that they do"